Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis

Neurology. 2009 Sep 29;73(13):1078; author reply 1078-9. doi: 10.1212/WNL.0b013e3181ab6e08.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adjuvants, Immunologic / administration & dosage
  • Adjuvants, Immunologic / adverse effects*
  • Atorvastatin
  • Disease Progression
  • Drug Therapy, Combination
  • Heptanoic Acids / administration & dosage
  • Heptanoic Acids / adverse effects*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
  • Interferon beta-1a
  • Interferon-beta / administration & dosage
  • Interferon-beta / adverse effects*
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*
  • Multiple Sclerosis, Relapsing-Remitting / pathology
  • Pyrroles / administration & dosage
  • Pyrroles / adverse effects*

Substances

  • Adjuvants, Immunologic
  • Heptanoic Acids
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Pyrroles
  • Interferon-beta
  • Atorvastatin
  • Interferon beta-1a